Ichihara, Japan

Kenta Sakurada

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Sumitomo Chemical Company, Limited. Active years: 2022.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kenta Sakurada: Innovator in Biofilm Reduction Technologies

Introduction

Kenta Sakurada is a notable inventor based in Ichihara, Japan. He has made significant contributions to the field of materials science, particularly in the development of compositions that reduce biofilm adhesion. His innovative work is recognized for its potential applications in various industries.

Latest Patents

Kenta Sakurada holds a patent for a composition and molded body designed to reduce the adhesion of biofilms. The invention provides a composition that includes at least one resin selected from thermoplastic and thermosetting resins, along with a quorum sensing inhibitor. The specific parameters of the composition ensure its effectiveness, making it a valuable asset in the production of molded bodies.

Career Highlights

Kenta Sakurada is currently employed at Sumitomo Chemical Company, Limited, where he continues to advance his research and development efforts. His work has led to the creation of innovative solutions that address critical challenges in material adhesion and biofilm management.

Collaborations

Kenta collaborates with esteemed colleagues such as Eiji Nitta and Takaya Ichimiya. Their combined expertise fosters a productive environment for innovation and development within their field.

Conclusion

Kenta Sakurada's contributions to the field of biofilm reduction technologies highlight his role as a leading inventor. His patented compositions represent a significant advancement in material science, showcasing the importance of innovation in addressing real-world challenges.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…